Anixa Biosciences (ANIX) Non Operating Investment Income (2012 - 2013)
Anixa Biosciences' (ANIX) quarterly Non Operating Investment Income came in at $290194.0 in Q2 2013, up 170.29% YoY from $107364.0 in Q2 2012, and up 170.29% on a QoQ basis from -$412853.0 in Q2 2012.
Anixa Biosciences (ANIX) Non Operating Investment Income (2012 - 2013) Analysis & Trends
Anixa Biosciences (ANIX) has 2 years of Non Operating Investment Income data on file, last reported at $290194.0 in Q2 2013.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Operating Investment Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | - |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | - |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | - |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | - |
| 10 | Anixa Biosciences | 123.62 Mn | 123.62 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 30, 2013 | 290,194.00 |
| Apr 30, 2013 | 290,194.00 |
| Apr 30, 2012 | -412,853.00 |
| Apr 30, 2012 | -412,853.00 |